181 related articles for article (PubMed ID: 33516148)
1. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
Heudel P; Chabaud S; Perol D; Flechon A; Fayette J; Combemale P; Tredan O; Desseigne F; de la Fouchardiere C; Boyle H; Perol M; Bachelot T; Cassier P; Avrillon V; Terret C; Michallet AS; Neidhardt-Berard EM; Nicolas-Virelizier E; Dufresne A; Belhabri A; Brahmi M; Lebras L; Nicolini F; Sarabi M; Rey P; Bonneville-Levard A; Rochefort P; Provensal AM; Eberst L; Assaad S; Swalduz A; Saintigny P; Toussaint P; Guillermin Y; Castets M; Coutzac C; Meeus P; Dupré A; Durand T; Crochet H; Fervers B; Gomez F; Rivoire M; Gregoire V; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Lasset C; Chvetzoff G; Mehlen P; Beaupère S; Zrounba P; Ray-Coquard I; Blay JY
ESMO Open; 2021 Feb; 6(1):100044. PubMed ID: 33516148
[TBL] [Abstract][Full Text] [Related]
2. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study.
Ruan Z; Zhang Y; Li Z; Jiang J; Luo W; Quan Q; Xu Z; Lei J; Peng R
Clin Exp Med; 2023 Dec; 23(8):5051-5062. PubMed ID: 37555912
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016.
Deng W; Wang Y; Liu X; Liu J; Wang L; Yang Z; Yang M; An Y; Tang C; Sanford NN; Kim BYS; Jiang W
JAMA Netw Open; 2020 Dec; 3(12):e2028627. PubMed ID: 33295975
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.
Morais S; Antunes L; Bento MJ; Lunet N
Cancer Epidemiol; 2017 Oct; 50(Pt A):85-91. PubMed ID: 28843176
[TBL] [Abstract][Full Text] [Related]
6. Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal.
Gonçalves E; Fontes F; Rodrigues JR; Calisto R; Bento MJ; Lunet N; Morais S
Breast Cancer Res Treat; 2024 Apr; 204(2):367-376. PubMed ID: 38151690
[TBL] [Abstract][Full Text] [Related]
7. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
Heudel PE; Fervers B; Durand T; Chabaud S; Michallet AS; Gomez F; Rivoire M; Bachelot T; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Chvetzoff G; Pérol D; Blay JY
Int J Clin Oncol; 2021 Oct; 26(10):1793-1804. PubMed ID: 34091824
[TBL] [Abstract][Full Text] [Related]
8. Incidence of second primary cancers in North Portugal-a population-based study.
Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
[TBL] [Abstract][Full Text] [Related]
9. The effect of a gastric second primary cancer on the survival of patients with a previous cancer history.
Morais S; Antunes L; Bento MJ; Lunet N
Eur J Cancer Prev; 2020 May; 29(3):215-221. PubMed ID: 31651567
[TBL] [Abstract][Full Text] [Related]
10. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
[TBL] [Abstract][Full Text] [Related]
11. Risk of Gynecologic Cancer as Second versus First Primary Cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract][Full Text] [Related]
12. Suicide rates among patients with first and second primary cancer.
Jiang Y; Wang Y; Cheng X; Zhou Z; Wang J; Yu H; Yao G; Lu Z; Chen X; Yan S; Zhao F
Epidemiol Psychiatr Sci; 2023 Sep; 32():e57. PubMed ID: 37711033
[TBL] [Abstract][Full Text] [Related]
13. Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.
Heudel PE; de Montfort A; Debieuvre D; Chouaid C; Carton M; Audigier-Valette C; Filleron T; Chabaud S; Stancu A; Quantin X; Hiret S; Bosquet L; Blay JY
Lung Cancer; 2023 Aug; 182():107280. PubMed ID: 37339550
[TBL] [Abstract][Full Text] [Related]
14. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
[TBL] [Abstract][Full Text] [Related]
15. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract][Full Text] [Related]
16. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
17. Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles.
Morais S; Castro C; Antunes L; Peleteiro B; Bento MJ; Lunet N
Eur J Cancer Prev; 2019 May; 28(3):159-166. PubMed ID: 29668653
[TBL] [Abstract][Full Text] [Related]
18. Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues.
Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
Clin Epidemiol; 2020; 12():857-864. PubMed ID: 32821171
[TBL] [Abstract][Full Text] [Related]
19. Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis.
Chen X; Zhang Z; Hou X; Zhang Y; Zhou T; Liu J; Lin Z; Fang W; Yang Y; Ma Y; Huang Y; Zhao H; Zhang L
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32863271
[TBL] [Abstract][Full Text] [Related]
20. The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trials.
Fujiwara Y; Horita N; Namkoong H; Galsky MD
Eur J Cancer; 2021 Jun; 150():168-178. PubMed ID: 33906099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
